Canaccord Genuity Group Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price

Privia Health Group (NASDAQ:PRVA) had its target price upped by Canaccord Genuity Group from $29.00 to $30.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Several other research firms have also issued reports on PRVA. Stephens reiterated an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. Truist Financial increased their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. JMP Securities restated a “market outperform” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Friday, February 14th. Finally, Barclays increased their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $26.59.

Privia Health Group Price Performance

NASDAQ PRVA opened at $24.97 on Friday. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $26.04. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of 249.72, a PEG ratio of 3.47 and a beta of 0.87. The company has a fifty day moving average price of $22.40 and a 200-day moving average price of $20.59.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. FMR LLC grew its holdings in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after purchasing an additional 271,645 shares during the last quarter. Durable Capital Partners LP grew its holdings in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after purchasing an additional 378,255 shares during the last quarter. Riverbridge Partners LLC grew its holdings in shares of Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after purchasing an additional 23,178 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Privia Health Group by 19.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company’s stock worth $29,110,000 after purchasing an additional 246,393 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.